Work

Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial

Year: 2007

Type: article

Study design: Clinical Trial

Source: Journal of Gastrointestinal Cancer

DOI: 10.1007/s12029-007-9007-6

Authors: Steven R. Alberts, Vera J. Suman, Henry C. Pitot, John K. Camoriano, Joseph Rubin

Institutions: Mayo Clinic, Scottsdale Community College

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Health and Human Services, Mayo Clinic, National Institutes of Health, National Cancer Institute

Awards: G358241105, G42877212, Community Clinical Oncology Program, North Central Cancer Treatment Group, G688707633, Scottsdale Community Clinical Oncology Program

OpenAlex ID: W2054590793

FWCI: 0.608

Cites: 27

Cited by: 13

Related to: 10